|
Volumn 3, Issue 1, 1996, Pages 39-47
|
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor
|
Author keywords
Interleukin 2; Melanoma; Neoplasms; Vaccine
|
Indexed keywords
CD3 ANTIGEN;
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
ANIMAL;
ARTICLE;
C57BL MOUSE;
CELL CULTURE;
EXPERIMENTAL MELANOMA;
GENE EXPRESSION;
GENE THERAPY;
GENE TRANSFER;
GENETICS;
IMMUNOLOGY;
IMMUNOTHERAPY;
LYMPH NODE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
METASTASIS;
METHODOLOGY;
MOLECULAR GENETICS;
MOUSE;
NUCLEOTIDE SEQUENCE;
SECRETION;
T LYMPHOCYTE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD3;
BASE SEQUENCE;
GENE EXPRESSION;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
IMMUNOTHERAPY;
INTERFERON TYPE II;
INTERLEUKIN-2;
LYMPH NODES;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
MOLECULAR SEQUENCE DATA;
T-LYMPHOCYTES;
TUMOR CELLS, CULTURED;
|
EID: 0029685801
PISSN: 09291903
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (70)
|
References (6)
|